Search
Cogent Biosciences Inc
COGTAdd to Watchlist
34.540USD
+0.870+2.58%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.90BMarket Cap
LossP/E TTM
Cogent Biosciences Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Cogent Biosciences Inc is 8.62, ranking 106 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -15.98, which is -87.28% below the recent high of -2.03 and -35.48% above the recent low of -21.65.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
